You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

triple negative breast cancer, neoadjuvant, pembrolizumab

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab injection
  • +2 more
  • (no location specified)
Jul 25, 2023

Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 15, 2023

Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

Not yet recruiting
  • Breast Cancer Triple Negative
  • +3 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    May 18, 2023

    Breast Cancer Trial in Houston (Sacituzumab Govitecan, Pembrolizumab)

    Not yet recruiting
    • Breast Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 22, 2022

    Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • (no location specified)
    Oct 5, 2023

    Breast Cancer Trial in Beijing (Pembrolizumab, Paclitaxel, Epirubicin)

    Recruiting
    • Breast Cancer
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Dec 28, 2022

    Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • +7 more
    • (no location specified)
    Aug 1, 2022

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Not yet recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +3 more
    • Pembrolizumab
    • +5 more
    • (no location specified)
    Apr 12, 2023

    Triple Negative Breast Cancer Trial in United States (Sacituzumab govitecan-hziy (SG), Pembrolizumab, Capecitabine)

    Recruiting
    • Triple Negative Breast Cancer
    • Sacituzumab govitecan-hziy (SG)
    • +2 more
    • Glendale, Arizona
    • +7 more
    Jan 26, 2023

    Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

    Recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
    • Fairway, Kansas
    • +5 more
    Jan 26, 2023

    Breast Cancer, Breast Tumors Trial in Portland (Pembrolizumab, IRX 2)

    Recruiting
    • Breast Cancer
    • Breast Neoplasms
    • Portland, Oregon
      Providence Portland Medical Center
    Jan 31, 2022

    Triple-negative Breast Cancer Trial in United States (Carboplatin, Docetaxel, Pembrolizumab)

    Active, not recruiting
    • Triple-negative Breast Cancer
    • Fairway, Kansas
    • +8 more
    Jun 6, 2022

    Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)

    Active, not recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
    • Los Alamitos, California
    • +6 more
    Jan 25, 2023

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 16, 2022

    Invasive Breast Cancer, Triple Negative Breast Cancer, ER-Negative Breast Cancer Trial in Boston, Danvers, Newton (Sacituzumab

    Active, not recruiting
    • Invasive Breast Cancer
    • +4 more
    • Boston, Massachusetts
    • +4 more
    Oct 25, 2021

    Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Residual Disease
    • (no location specified)
    Nov 15, 2023

    Checkpoint Inhibitors in Triple Negative Breast

    Recruiting
    • Triple Negative Breast Cancer
    • Whole Genome Sequencing
    • +7 more
    • Barcelona, Spain
      Vall d'Hebron Institute of Oncology
    Jun 20, 2023

    Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Cancer
    • Charlotte, North Carolina
      Levine Cancer Institute
    Aug 31, 2023

    Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)

    Suspended
    • Triple Negative Breast Cancer
    • Anthracycline-refractory TNBC
    • Houston, Texas
      Houston Methodist Cancer Center
    Mar 28, 2022

    Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • Xiaopi granules
    • +2 more
    • (no location specified)
    Nov 22, 2023

    Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)

    Not yet recruiting
    • Triple-negative Breast Cancer
    • Taxane and Carboplatin
    • +2 more
    • (no location specified)
    Apr 25, 2023

    Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph

    Recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Radiation Therapy Boost
    • +6 more
    • Washington, District of Columbia
    • +8 more
    Dec 5, 2022

    Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Dhaka, Bangladesh
      Bangabandhu Sheikh Mujib Medical University
    May 24, 2023

    Metastatic Malignant Tumor in the Bone, Stage IV Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma Trial in

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Bone
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jan 4, 2023

    BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

    Completed
    • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
    • Barretos, SP, Brazil
      Barretos Cancer Hospital
    Dec 25, 2022